Jennifer A. Wargo

6 ta ish

The University of Texas MD Anderson Cancer Center

1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

   Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

   Maqola20177 iqtibos

   ABIABI:AkademIndex/2026.other.339918

2. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

   Deborah Nejman, Ilana Livyatan, Garold Fuks +58

   Maqola20204 iqtibos

   ABIABI:AkademIndex/2026.other.468901

3. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

   Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1

   Sharh maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.748211

4. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

   Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.468906

5. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

   Leore T. Geller, Michal Barzily-Rokni, Tal Danino +44

   Maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.547144

6. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

   Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan +86

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.468922